Published in Anticancer Res on May 13, 1998
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J Clin Immunol (2006) 0.91
Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications. Evid Based Complement Alternat Med (2005) 0.90
Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation. Br J Cancer (2003) 0.86
Preclinical and clinical effects of mistletoe against breast cancer. Biomed Res Int (2014) 0.83
Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata). BMC Complement Altern Med (2007) 0.81
Novel protein kinases associated with calcineurin B-like calcium sensors in Arabidopsis. Plant Cell (1999) 2.02
Implant infections: a haven for opportunistic bacteria. J Hosp Infect (2001) 1.49
Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res (2004) 1.33
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Antimicrobial substances and effects on sessile bacteria. Zentralbl Bakteriol (1999) 0.97
Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res (2004) 0.93
Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment. Anticancer Res (1996) 0.92
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). Anticancer Res (1999) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid. Med Microbiol Immunol (1988) 0.90
Preclinical evaluation of a novel water-soluble chlorin E6 derivative (BLC 1010) as photosensitizer for the closure of the neovessels. Photochem Photobiol (2005) 0.89
Keyhole limpet hemocyanin for carcinoma in situ of the bladder: a long-term follow-up study. Eur Urol (2000) 0.88
[Special aspects of implant-associated infection in orthopedic surgery. From the pathophysiology to custom-tailored prevention strategies]. Orthopade (2004) 0.88
The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother (2000) 0.87
Immunomodulation by propionibacteria. Zentralbl Bakteriol (1990) 0.87
[Immunomodulating effects of antibiotics influencing digestive flora]. Pathol Biol (Paris) (1993) 0.86
Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma. Anticancer Res (1996) 0.84
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study. Diabetologia (2003) 0.84
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature. Zentralbl Bakteriol (1996) 0.84
Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res (1994) 0.84
The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection. Am J Med (1999) 0.84
Type of fimbriation determines adherence of Klebsiella bacteria to human epithelial cells. Zentralbl Bakteriol (1990) 0.83
The influence of a steroid hormone and of physical exercise on protein metabolism in rats. Exp Clin Endocrinol (1988) 0.83
Silver coating of medical devices for catheter-associated infections? Am J Med (1999) 0.83
Biological properties of staphylococcal lipoteichoic acid and related macromolecules. Zentralbl Bakteriol (1990) 0.82
Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci (2006) 0.82
Immunostimulating staphylococcal lipoteichoic acid prevents pulmonary tumor colonization in BALB/c-mice. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.82
Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models. Cancer Lett (2001) 0.81
Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice. Anticancer Res (2002) 0.81
Infrastructure and clinical practice for the detection and management of trauma-associated haemorrhage and coagulopathy. Eur J Trauma Emerg Surg (2014) 0.81
Influence of complementary Viscum album (Iscador) administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy. Anticancer Res (2005) 0.81
Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res (2000) 0.81
Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol (1987) 0.81
Silver-containing polymers. Antimicrob Agents Chemother (1999) 0.81
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci. Zentralbl Bakteriol (1998) 0.80
Characterization of a T-DNA insertion mutant for the protein import receptor atToc33 from chloroplasts. Mol Genet Genomics (2004) 0.80
Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture. J Hosp Infect (2000) 0.80
Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models. Anticancer Res (2003) 0.80
Modification of glycosylation by tunicamycin treatment inhibits lectin-mediated adhesion of Streptococcus pneumoniae to various tissues. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.79
The influence of pH and methylene blue on the pathways of glucose utilization and lactate formation in erythrocytes of man. Eur J Biochem (1971) 0.79
Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine. In Vivo (2010) 0.79
"Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review. Acta Microbiol Immunol Hung (2000) 0.79
Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice. J Cancer Res Clin Oncol (1988) 0.79
Novel strategies to prevent catheter-associated infections in oncology patients. J Chemother (2001) 0.79
Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder. Anticancer Res (1996) 0.79
Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Zentralbl Bakteriol (1990) 0.78
Liver lectins: mediators for metastases? Experientia (1983) 0.78
Adherent bacteria and activity of antibiotics. J Antimicrob Chemother (1999) 0.78
The influence of high glycine diets on the activity of glycine-catabolizing enzymes and on glycine catabolism in rats. J Nutr (1986) 0.78
Influence of 12 antibiotics on antitumor immunity in BALB/c-mice. Zentralbl Bakteriol (1992) 0.77
Activation of mononuclear immune cells in response to staphylococcal lipoteichoic acid. Zentralbl Bakteriol (1991) 0.77
Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma. Anticancer Res (1998) 0.77
Are ABH antigenic determinants on human outer ear canal epithelium responsible for Pseudomonas aeruginosa infections? ORL J Otorhinolaryngol Relat Spec (1995) 0.77
Prevention of experimental liver metastases by arabinogalactan. Naturwissenschaften (1986) 0.77
Respiratory burst of human polymorphonuclear leukocytes in response to the galactoside-specific mistletoe lectin. Zentralbl Bakteriol (1995) 0.77
Genetic control of Rous sarcoma regression in inbred lines of chickens. Folia Biol (Praha) (1981) 0.77
Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res (1997) 0.77
Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listeriosis. Zentralbl Bakteriol (1996) 0.76
Anti-infective catheters: novel strategies to prevent nosocomial infections in oncology. Anticancer Res (1999) 0.76
Murine thymocyte proliferation, maturation and emigration in response to selenium. Arzneimittelforschung (1996) 0.76
Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB/c mice. Folia Biol (Praha) (1993) 0.76
Intestinal microflora of BALB/c-mice and function of local immune cells. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.75
The myth of encrustation inhibiting materials. J Hosp Infect (1999) 0.75
The quantity and duration of the antimicrobial efficacy of a chlorhexidine and silversulfadiazine impregnated catheter. J Hosp Infect (1999) 0.75
Central venous catheters and bloodstream infection. JAMA (2000) 0.75
Blood group phenotype determines lectin-mediated adhesion of Pseudomonas aeruginosa to human outer ear canal epithelium. Zentralbl Bakteriol (1995) 0.75
Chemiluminescence response of human polymorphonuclear leukocytes induced by purified, latex attached Klebsiella fimbriae. Zentralbl Bakteriol (1991) 0.75
Cell surface antigen of encapsulated Staphylococcus epidermidis ATCC 31432. J Clin Microbiol (1987) 0.75
[Incidence of vasoneuroses and teleangiectasias in patients with peptic ulceration and in healthy subjects (author's transl)]. Cesk Gastroenterol Vyz (1976) 0.75
[Pilot study of controlled retrospective analysis (retrolective study design) of care for type 2 diabetics since 1990]. Dtsch Med Wochenschr (2003) 0.75
Immunochemical characterization and biological properties of a cell surface antigen extracted from encapsulated Staphylococcus epidermidis strain SE-10. Zentralbl Bakteriol (1990) 0.75
Efficacy of local Bacillus Calmette-Guérin treatment in superficial bladder cancer relapsing under Keyhole-Limpet Hemocyanin immunotherapy. Zentralbl Bakteriol (1995) 0.75
[Unconventional cancer therapy on trial. Mistletoe preparations: only effective in the test tube?. Interview by Elke Runge]. MMW Fortschr Med (2000) 0.75
Liver lectin blocking with D-galactose to prevent hepatic metastases in colorectal carcinoma patients. Anticancer Res (1998) 0.75
Continuing education with built-in peer review. Bull Am Protestant Hosp Assoc (1977) 0.75
Low molecular thymic peptides stimulate human blood dendritic cells. Anticancer Res (2000) 0.75
Microflora-associated defense stimulating factors. Scand J Gastroenterol Suppl (1997) 0.75
Importance of lectins for the prevention of bacterial infections and cancer metastases. Zentralbl Bakteriol (1994) 0.75
Some comments on the derivation of the Wiener filter for average evoked potentials. Biol Cybern (1976) 0.75
Evidence for a self-fulfilling hypothesis: chlorhexidine dressing for reduction of microbial colonization of the skin with central venous catheters. J Hosp Infect (2000) 0.75
[Changes of vegetative reflexes and the cold test in patients with peptic ulcers and healthy subjects (author's transl)]. Cesk Gastroenterol Vyz (1976) 0.75
Admitting patients to the psychiatric unit. Bull Am Protestant Hosp Assoc (1976) 0.75
Combined immunomodulation (Propionibacterium avidum KP-40) and lectin blocking (D-galactose) prevents liver tumor colonization in BALB/c-mice. Zentralbl Bakteriol (1994) 0.75
Prevention of hepatic metastases by liver lectin blocking with D-galactose in colon cancer patients. A prospectively randomized clinical trial. Anticancer Res (1997) 0.75
Immunohistological findings in patients with superficial bladder carcinoma after intravesical instillation of keyhole limpet haemocyanin. Br J Urol (1995) 0.75
Adhesive properties of P-like fimbriae in Klebsiella-species. Zentralbl Bakteriol (1996) 0.75
Changes in immunological characteristics of white blood cells after administration of standardized mistletoe extract. In Vivo (2002) 0.75
Average evoked brain potential comparison on the basis of spectral and coherency functions. Biol Cybern (1976) 0.75
[In vitro activity of Mercurius cyanatus complex against relevant pathogenic bacterial isolates]. Arzneimittelforschung (1995) 0.75
Sophisticated medical devices as local drug-delivery systems. Med Device Technol (2000) 0.75
The role of ABO blood groups in infections induced by Staphylococcus saprophyticus and Pseudomonas aeruginosa. Zentralbl Bakteriol (1995) 0.75
Influence of Propionibacterium avidum KP-40 on the cellular immune system after intensive sport activity. Zentralbl Bakteriol (1996) 0.75
Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice. Anticancer Res (1997) 0.75
Prevention of liver-tumor colonization by combined immunomodulation and liver lectin blocking. Oncol Rep (1995) 0.75
Influence of propionibacterium avidum KP-40 on the proliferation, maturation, emigration and activity of thymocytes and monocytes. Zentralbl Bakteriol (1995) 0.75
The recombinant human histones H1 zero and H1.2 cause different toxicity profiles on the human leukemia cell line K562. Anticancer Res (2000) 0.75
Prevention of hepatic metastases by liver lectin blocking with D-galactose in stomach cancer patients. A prospectively randomized clinical trial. Anticancer Res (1997) 0.75
Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA). Anticancer Res (2003) 0.75
Wiener filtration versus averaging of evoked responses. Biol Cybern (1977) 0.75